Supplementary Figure 2.jpg (757.29 kB)
Supplementary Figure 2. Treatment patterns in patients with metastatic non-small-cell lung cancer in the era of immunotherapy
figure
posted on 2021-04-14, 10:19 authored by David Stenehjem, Solomon Lubinga, Keith A Betts, Wenxi Tang, Mads Jenkins, Yongqin YuanYongqin Yuan, John Hartman, Sumati Rao, Jenny LamJenny Lam, David WaterhouseDavid Waterhouse|
Sankey diagram of treatment patterns for patients initiating 1L therapy between August to December 2018 (A), January to June 2019 (B) and July to December 2019 (C). 1L: first-line; 2L: second-line; 3L: third-line; Nivo: nivolumab; Pembro: pembrolizumab. |
